Evoke plc (LON:EVOK – Get Free Report) shares dropped 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on the stock. Berenberg Bank decreased their price target on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a research report on Monday, December 16th.
Get Our Latest Report on Evoke
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last posted its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Equities research analysts predict that Evoke plc will post 12.7648305 EPS for the current year.
Insider Buying and Selling
In other news, insider Andrea Gisle Joosen acquired 14,572 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). 27.00% of the stock is owned by company insiders.
About Evoke
See Also
- Five stocks we like better than Evoke
- What is the NASDAQ Stock Exchange?
- MarketBeat Week in Review – 03/24 – 03/28
- What Investors Need to Know About Upcoming IPOs
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Short a Stock in 5 Easy Steps
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.